• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氯丙嗪诱发的免疫病:血清IgM进行性升高。

Chlorpromazine-induced immunopathy: progressive increase in serum IgM.

作者信息

Zucker S, Zarrabi H M, Schubach W H, Varma A, Derman R, Lysik R M, Habicht G, Seitz P M

机构信息

Department of Medicine, Veterans Administration Medical Center, Northport, NY 11768.

出版信息

Medicine (Baltimore). 1990 Mar;69(2):92-100.

PMID:2319941
Abstract

Long-term chlorpromazine therapy has been associated with the asymptomatic development of a high incidence of antinuclear antibodies, coagulation inhibitors, and increased serum levels of IgM. The purpose of this study has been to characterize the natural history of this chlorpromazine-induced (CPZ) immunopathy. To this end we carried out a prospective study of schizophrenic patients with the immunopathy to compare the effect of continuing CPZ versus switching to haloperidol therapy. Although no marked differences were noted between the 2 groups at the end of 5 years, 6 of 29 patients who continued to receive CPZ, as compared to none of 14 patients on haloperidol, had progressive elevations of serum IgM. In spite of a high incidence of antinuclear antibodies, none of the patients developed a lupus-like syndrome. One patient, however, who had been maintained on CPZ for more than 15 years, developed Waldenström macroglobulinemia, as characterized by an IgM monoclonal gammopathy and a lymphocyte immunoglobulin heavy and kappa light chain gene rearrangement. Another CPZ-treated patient developed immune thrombocytopenia. Based on the potential serious sequelae of prolonged stimulation of the immune system by CPZ, we recommend that patients who develop an increase in serum IgM while on CPZ be switched to other types of anti-psychotic medications.

摘要

长期使用氯丙嗪治疗与抗核抗体、凝血抑制剂高发生率的无症状发展以及血清IgM水平升高有关。本研究的目的是描述这种氯丙嗪诱导的(CPZ)免疫病的自然病程。为此,我们对患有这种免疫病的精神分裂症患者进行了一项前瞻性研究,以比较继续使用CPZ与改用氟哌啶醇治疗的效果。尽管在5年末两组之间未发现明显差异,但继续接受CPZ治疗的29例患者中有6例血清IgM呈进行性升高,而接受氟哌啶醇治疗的14例患者中无一例如此。尽管抗核抗体发生率很高,但没有患者出现狼疮样综合征。然而,有1例患者接受CPZ治疗超过15年,发展为瓦尔登斯特伦巨球蛋白血症,其特征为IgM单克隆丙种球蛋白病以及淋巴细胞免疫球蛋白重链和κ轻链基因重排。另1例接受CPZ治疗的患者发生了免疫性血小板减少症。基于CPZ长期刺激免疫系统可能产生的严重后果,我们建议在使用CPZ期间血清IgM升高的患者改用其他类型的抗精神病药物。

相似文献

1
Chlorpromazine-induced immunopathy: progressive increase in serum IgM.氯丙嗪诱发的免疫病:血清IgM进行性升高。
Medicine (Baltimore). 1990 Mar;69(2):92-100.
2
Characteristics of human immunodeficiency virus and chlorpromazine induced antiphospholipid antibodies: effect of beta 2 glycoprotein I on binding to phospholipid.人类免疫缺陷病毒和氯丙嗪诱导的抗磷脂抗体的特征:β2糖蛋白I对与磷脂结合的影响。
J Rheumatol. 1994 Jan;21(1):94-9.
3
Chlorpromazine-induced lupus anticoagulant and associated immunologic abnormalities.氯丙嗪诱导的狼疮抗凝物及相关免疫异常。
Am J Hematol. 1982 Sep;13(2):121-9. doi: 10.1002/ajh.2830130204.
4
Replacement of chlorpromazine with other neuroleptics: effect on abnormal skin pigmentation and ocular changes.用其他抗精神病药物替代氯丙嗪:对皮肤色素沉着异常和眼部变化的影响。
J Psychiatry Neurosci. 1993 Jul;18(4):173-7.
5
Immunologic and coagulation disorders in chlorpromazine-treated patients.氯丙嗪治疗患者的免疫和凝血障碍
Ann Intern Med. 1979 Aug;91(2):194-9. doi: 10.7326/0003-4819-91-2-194.
6
Antinuclear antibodies in chronic psychotic patients treated with chlorpromazine.接受氯丙嗪治疗的慢性精神病患者中的抗核抗体。
Am J Psychiatry. 1975 Nov;132(11):1204-6. doi: 10.1176/ajp.132.11.1204.
7
IgM inhibitors of the contact activation phase of coagulation in chlorpromazine-treated patients.氯丙嗪治疗患者中凝血接触激活阶段的IgM抑制剂。
Br J Haematol. 1978 Nov;40(3):447-57. doi: 10.1111/j.1365-2141.1978.tb05816.x.
8
Hypogammaglobulinemia during antipsychotic therapy.抗精神病药物治疗期间的低丙种球蛋白血症。
Psychiatry Clin Neurosci. 1998 Feb;52(1):115-7. doi: 10.1111/j.1440-1819.1998.tb00983.x.
9
Initial immunoglobulin M 'flare' after rituximab therapy in patients diagnosed with Waldenstrom macroglobulinemia: an Eastern Cooperative Oncology Group Study.利妥昔单抗治疗诊断为华氏巨球蛋白血症患者后的初始免疫球蛋白M“激增”:一项东部肿瘤协作组研究
Cancer. 2004 Dec 1;101(11):2593-8. doi: 10.1002/cncr.20658.
10
Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials.类风湿关节炎患者接受肿瘤坏死因子α单克隆抗体英夫利昔单抗治疗后诱导产生的抗双链DNA抗体评估:开放标签试验和随机安慰剂对照试验的结果
Arthritis Rheum. 2000 Nov;43(11):2383-90. doi: 10.1002/1529-0131(200011)43:11<2383::AID-ANR2>3.0.CO;2-D.

引用本文的文献

1
The antipsychotic chlorpromazine reduces neuroinflammation by inhibiting microglial voltage-gated potassium channels.抗精神病药物氯丙嗪通过抑制小胶质细胞电压门控钾通道来减轻神经炎症。
Glia. 2025 Jan;73(1):210-227. doi: 10.1002/glia.24629. Epub 2024 Oct 22.
2
Chlorpromazine, a Clinically Approved Drug, Inhibits SARS-CoV-2 Nucleocapsid-Mediated Induction of IL-6 in Human Monocytes.氯丙嗪,一种临床批准的药物,抑制 SARS-CoV-2 核衣壳介导的人单核细胞中白细胞介素 6 的诱导。
Molecules. 2022 Jun 7;27(12):3651. doi: 10.3390/molecules27123651.
3
Chlorpromazine as a Potential Antipsychotic Choice in COVID-19 Treatment.
氯丙嗪作为新冠病毒肺炎治疗中一种潜在的抗精神病药物选择
Front Psychiatry. 2020 Dec 23;11:612347. doi: 10.3389/fpsyt.2020.612347. eCollection 2020.
4
The Large Action of Chlorpromazine: Translational and Transdisciplinary Considerations in the Face of COVID-19.氯丙嗪的重大作用:面对新冠疫情的转化与跨学科思考
Front Pharmacol. 2020 Dec 16;11:577678. doi: 10.3389/fphar.2020.577678. eCollection 2020.
5
Repurposing chlorpromazine to treat COVID-19: The reCoVery study.氯丙嗪治疗 COVID-19 的再利用:reCoVery 研究。
Encephale. 2020 Jun;46(3):169-172. doi: 10.1016/j.encep.2020.05.006. Epub 2020 May 16.
6
[Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study].[氯丙嗪在新冠病毒肺炎治疗中的重新应用:恢复研究]
Encephale. 2020 Jun;46(3S):S35-S39. doi: 10.1016/j.encep.2020.04.010. Epub 2020 Apr 29.
7
MALT1 Proteolytic Activity Suppresses Autoimmunity in a T Cell Intrinsic Manner.MALT1 蛋白水解酶活性以 T 细胞内在的方式抑制自身免疫。
Front Immunol. 2019 Aug 14;10:1898. doi: 10.3389/fimmu.2019.01898. eCollection 2019.